167 related articles for article (PubMed ID: 2941264)
1. Experience with ciprofloxacin in the treatment of various infections caused mainly by Pseudomonas aeruginosa.
Giamarellou H; Daphnis E; Dendrinos C; Daikos GK
Drugs Exp Clin Res; 1985; 11(5):351-6. PubMed ID: 2941264
[TBL] [Abstract][Full Text] [Related]
2. Use of intravenous ciprofloxacin in difficult-to-treat infections.
Giamarellou H; Galanakis N
Am J Med; 1987 Apr; 82(4A):346-51. PubMed ID: 3555059
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of ciprofloxacin in the treatment of Pseudomonas aeruginosa infections.
Giamarellou H; Galanakis N; Dendrinos C; Stefanou J; Daphnis E; Daikos GK
Eur J Clin Microbiol; 1986 Apr; 5(2):232-5. PubMed ID: 2941288
[TBL] [Abstract][Full Text] [Related]
4. Oral ciprofloxacin in the treatment of elderly patients with complicated urinary tract infections due to trimethoprim/sulfamethoxazole-resistant bacteria.
Preheim LC; Cuevas TA; Roccaforte JS; Mellencamp MA; Bittner MJ
Am J Med; 1987 Apr; 82(4A):295-300. PubMed ID: 3555051
[TBL] [Abstract][Full Text] [Related]
5. Experience with ciprofloxacin in vitro and in vivo.
Giamarellou H; Efstratiou A; Tsagarakis J; Petrikkos G; Daikos GK
Arzneimittelforschung; 1984; 34(12):1775-8. PubMed ID: 6442151
[TBL] [Abstract][Full Text] [Related]
6. Clinical efficacy of ciprofloxacin therapy for gram-negative bacillary osteomyelitis.
Hessen MT; Ingerman MJ; Kaufman DH; Weiner P; Santoro J; Korzeniowski OM; Boscia J; Topiel M; Bush LM; Kaye D
Am J Med; 1987 Apr; 82(4A):262-5. PubMed ID: 3555045
[TBL] [Abstract][Full Text] [Related]
7. Clinical experience with parenteral and oral ofloxacin in severe infections.
Kanellakopoulou K; Giamarellou H
Scand J Infect Dis Suppl; 1990; 68():64-9. PubMed ID: 2218425
[TBL] [Abstract][Full Text] [Related]
8. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience.
Hansen CR; Pressler T; Høiby N
J Cyst Fibros; 2008 Nov; 7(6):523-30. PubMed ID: 18693078
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients.
Cantón R; Cobos N; de Gracia J; Baquero F; Honorato J; Gartner S; Alvarez A; Salcedo A; Oliver A; García-Quetglas E;
Clin Microbiol Infect; 2005 Sep; 11(9):690-703. PubMed ID: 16104983
[TBL] [Abstract][Full Text] [Related]
10. Ciprofloxacin in the treatment of acute and chronic osteomyelitis: a review.
Norrby SR
Scand J Infect Dis Suppl; 1989; 60():74-8. PubMed ID: 2667110
[TBL] [Abstract][Full Text] [Related]
11. Ciprofloxacin: an update on clinical experience.
Arcieri G; Griffith E; Gruenwaldt G; Heyd A; O'Brien B; Becker N; August R
Am J Med; 1987 Apr; 82(4A):381-6. PubMed ID: 3555063
[TBL] [Abstract][Full Text] [Related]
12. Oral ciprofloxacin in resistant urinary tract infections.
Ryan JL; Berenson CS; Greco TP; Mangi RJ; Sims M; Thornton GF; Andriole VT
Am J Med; 1987 Apr; 82(4A):303-6. PubMed ID: 3555052
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of the treatment with oral ciprofloxacin: experience with 24 patients].
Parras F; Torroba L; Buzón L; Martínez-Beltrán J; Loza E; Baquero F
Enferm Infecc Microbiol Clin; 1989 May; 7(5):261-5. PubMed ID: 2490722
[TBL] [Abstract][Full Text] [Related]
14. Ciprofloxacin for the treatment of chronic ear disease.
Piccirillo JF; Parnes SM
Laryngoscope; 1989 May; 99(5):510-3. PubMed ID: 2651829
[TBL] [Abstract][Full Text] [Related]
15. Resistance of Pseudomonas to ciprofloxacin: implications for the treatment of malignant otitis externa.
Bernstein JM; Holland NJ; Porter GC; Maw AR
J Laryngol Otol; 2007 Feb; 121(2):118-23. PubMed ID: 16995959
[TBL] [Abstract][Full Text] [Related]
16. Emergence of ciprofloxacin-resistant pseudomonas in chronic suppurative otitis media.
Jang CH; Park SY
Clin Otolaryngol Allied Sci; 2004 Aug; 29(4):321-3. PubMed ID: 15270816
[TBL] [Abstract][Full Text] [Related]
17. [Current therapeutical management, new antibiotics and treatment of Pseudomonas aeruginosa in bacterial ENT-infections].
Elies W
Laryngorhinootologie; 2002 Jan; 81(1):40-5. PubMed ID: 11845401
[TBL] [Abstract][Full Text] [Related]
18. [Ciprofloxacin: an alternative oral treatment in respiratory Pseudomonas infection in cystic fibrosis].
Magni A; Pradal U; Cazzola G; Mastella G
Pediatr Med Chir; 1990; 12(5):531-4. PubMed ID: 2087426
[TBL] [Abstract][Full Text] [Related]
19. Oral ciprofloxacin in refractory gram-negative bacillary infections.
Bryant RE; Hartstein AI
Int J Clin Pharmacol Res; 1987; 7(3):187-94. PubMed ID: 3596862
[TBL] [Abstract][Full Text] [Related]
20. Ciprofloxacin in severe infections.
Aswapokee N; Pruksachatvuthi S; Aswapokee P
J Med Assoc Thai; 1990 Jun; 73(6):315-20. PubMed ID: 2230626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
